Björn Peters, Joachim Beige, Justyna Siwy, Michael Rudnicki, Ralph Wendt, Alberto Ortiz, Ana Belen Sanz, Harald Mischak, Heather N Reich, Salmir Nasic, Dana Mahmood, Anders Persson, Anders Fernström, Maria Weiner, Bernd Stegmayr
BACKGROUND AND AIMS: IgA-nephropathy (IgAN) frequently leads to kidney failure. The urinary proteomics-based classifier IgAN237 may predict disease progression at the time of kidney biopsy. We studied whether IgAN237 predicts progression also later in the course of IgAN. METHOD: Urine from patients with biopsy-proven IgAN was analyzed using capillary electrophoresis-mass spectrometry at baseline (IgAN237-1, n = 103) and at follow-up (IgAN237-2, n = 89). Patients were categorized as 'non-progressors' (IgAN237 ≤0...
June 22, 2023: Nephrology, Dialysis, Transplantation